Warning letter
A2Z Industries, LLC: warning letter of Feb 9, 2015
FDA warning letter 407949 · Los Angeles District Office
Key facts
| Reference number | 407949 |
|---|---|
| Company | A2Z Industries, LLC |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Feb 9, 2015 |
| Posted date | Feb 16, 2015 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.5, 101.4(h)(1), 101.9(b), 101.9(b)(2), 101.36(b)(1), 101.36(b)(2)(i), 201.5 |
| Inspection city | Glendale |
| Inspection ZIP | 91203 |
| Inspection start date | Apr 17, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: